百万分子挑战:一个月球项目,以快速推进长寿干预发现
Mitchell B Lee1, Benjamin Blue2, Michael Muir2
1Ora Biomedical, Inc., 12101 Tukwila International Blvd Suite 210, Seattle, WA, 98168, USA. mitchell@orabiomedical.com.
GeroScience
|July 11, 2023
概括
科学家们提出了"百万分子挑战",以加速使用C. elegans模型发现长寿干预措施. 该计划利用机器人和人工智能来对潜在的抗衰老药物进行高通量选,旨在推进预防医学.
科学领域:
- 老年学和预防医学.
- 生物技术和药物发现
- 模型生物研究研究
背景情况:
- 针对衰老是21世纪医学的一个关键前沿.
- 新型长寿干预措施的发展已经放缓.
- 现有的药物查方法缺乏对全动物研究的高通量能力.
研究的目的:
- 提出一个高通量系统,以加速长寿干预的发现.
- 引入"百万分子挑战"以对1,000,000项干预措施进行定量评估.
- 突出C. elegans和人工智能驱动平台在这个努力中的实用性.
主要方法:
- 使用模型生物C. elegans进行药物查.
- 实施自动数据采集和分析技术.
- 利用机器人和人工智能平台 (WormBot-AI) 进行高吞吐量评估.
主要成果:
- 拟议的方法允许对长寿进行公正的药物查.
- 该WormBot-AI平台可以以低成本评估每只动物的干预措施.
- "百万分子挑战"旨在在五年内选100万种干预措施.
结论:
- 高通量系统对于推进长寿研究至关重要.
- 结合C. elegans,机器人和人工智能,为加速药物发现提供了可行的途径,以实现健康的长寿.
- 这一举措有可能对预防医学产生重大影响.
更多相关视频
相关概念视频
Mitochondria
13.9K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
13.9K
PI3K/mTOR/AKT Signaling Pathway
3.7K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.7K


